Epigallocatechin gallate (EGCG) reduces the intensity of pancreatic amyloid fibrils in human islet amyloid polypeptide (hIAPP) transgenic mice

Franko, Andras; Camargo, Diana C. Rodriguez; Boeddrich, Annett; Garg, Divita; Camargo, Andres Rodriguez; Rathkolb, Birgit; Janik, Dirk; Aichler, Michaela; Feuchtinger, Annette; Neff, Frauke; Fuchs, Helmut; Wanker, Erich E.; Reif, Bernd; Haering, Hans-Ulrich; Peter, Andreas; de Angelis, Martin Hrabe

dc.contributor.author	Frankó, András
dc.contributor.author	Häring, Hans-Ulrich
dc.contributor.author	Peter, Andreas
dc.date.accessioned	2019-12-03T11:01:29Z
dc.date.available	2019-12-03T11:01:29Z
dc.date.issued	2018
dc.identifier.issn	2045-2322
dc.identifier.uri	http://hdl.handle.net/10900/95242
dc.language.iso	en	de_DE
dc.publisher	Nature Publishing Group	de_DE
dc.relation.uri	http://dx.doi.org/10.1038/s41598-017-18807-8	de_DE
dc.subject.ddc	500	de_DE
dc.title	Epigallocatechin gallate (EGCG) reduces the intensity of pancreatic amyloid fibrils in human islet amyloid polypeptide (hIAPP) transgenic mice	de_DE
dc.type	Article	de_DE
utue.quellen.id	20190321153956_04020
utue.personen.roh	Franko, Andras
utue.personen.roh	Camargo, Diana C. Rodriguez
utue.personen.roh	Boeddrich, Annett
utue.personen.roh	Garg, Divita
utue.personen.roh	Camargo, Andres Rodriguez
utue.personen.roh	Rathkolb, Birgit
utue.personen.roh	Janik, Dirk
utue.personen.roh	Aichler, Michaela
utue.personen.roh	Feuchtinger, Annette
utue.personen.roh	Neff, Frauke
utue.personen.roh	Fuchs, Helmut
utue.personen.roh	Wanker, Erich E.
utue.personen.roh	Reif, Bernd
utue.personen.roh	Haering, Hans-Ulrich
utue.personen.roh	Peter, Andreas
utue.personen.roh	de Angelis, Martin Hrabe
dcterms.isPartOf.ZSTitelID	Scientific Reports	de_DE
dcterms.isPartOf.ZS-Issue	Article 1116	de_DE
dcterms.isPartOf.ZS-Volume	8	de_DE
utue.fakultaet	04 Medizinische Fakultät	de_DE